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ABSTRACT
Objective: The relationship between inflammatory
markers and depressive symptoms has been reported
inconsistently. Moreover, there were only a few studies
conducted in an Asian population. The purpose of this
study was to examine the association between C
reactive protein (CRP) and depressive symptoms in an
elderly Korean population.
Design, setting and participants: This study used
data from the Korean Social Life, Health and Aging
Project Health Examination Cohort, which started in
2011. Among participants aged 60 or over recruited
from a rural community, 569 (224 men and 345
women) without a history of stroke, angina pectoris,
myocardial infarction or CRP≥20 mg/L were employed
for cross-sectional analyses. As a marker of systemic
inflammation, CRP was measured. Depressive
symptoms were measured with the Center for
Epidemiologic Studies Depression (CES-D) scale.
Multiple linear regression analysis was used to
investigate the relationship between CRP and
depressive symptoms.
Results: In men, CRP levels had significant
associations with depressive symptoms before
(β=0.420, p=0.010) and after (β=0.336, p=0.025)
adjusting for age, body mass index, systolic blood
pressure, number of comorbidities, smoking status,
alcohol intake, marital status, education and sleep
duration. However, in women, the association between
CRP and depressive symptoms was not significant
before (p=0.250) and after (p=0.256) adjustment.
Conclusions: Our findings suggest that elevated CRP
levels are independently associated with the presence
of depressive symptoms in elderly Korean men.
INTRODUCTION
The elderly population is growing worldwide
and has been accompanied by a concurrent
increase in physical or psychological disabil-
ities.1 Depression is among the highly preva-
lent disorders in elderly people, and leads to
increased risk of mortality.2 The underlying
mechanisms for depressive symptoms in old
age remain unclear, but the inﬂammatory host
response is repeatedly inferred in the patho-
genesis of neuropsychiatric conditions.3 4 In
several population studies including older
participants, the relationship between inﬂam-
matory markers and depressive symptoms
has been described.2 5–13 However, those studies
have generated conﬂicting results. Some
studies observed positive associations between
inﬂammatory markers and depressive symp-
toms,2 5–9 11 but others did not.12 13 This
inconsistency might be due to differences in
study population, measurements of depres-
sion and control for important confounders.
Moreover, most of the reported data are
based on studies conducted in western coun-
tries, with only a few exceptions targeting the
Asian population.12 14
Thus, we investigated the independent asso-
ciation between serum C reactive protein
(CRP), a marker of systemic inﬂammation,
and depressive symptoms in an elderly Korean
population.
METHODS
Study population
The present study used data from the Korean
Social Life, Health and Aging Project
Strengths and limitations of this study
▪ We controlled sociodemographic, lifestyle, phys-
ical and psychological factors to evaluate the
independent association between serum CRP
levels and depressive symptoms.
▪ This study is the first to demonstrate that serum
CRP levels are associated with depressive symp-
toms in elderly Koreans.
▪ Limitations include a single measurement of
serum CRP and use of self-report questionnaires
for depressive symptoms.
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(KSHAP), which is a population-based longitudinal study
of health determinants among elderly Koreans. The
target populations of the KSHAP are people aged
60 years or older and their spouses living within one
township (myeon) of Ganghwa-gun, Incheon, Korea.
This township is a typical rural Korean village where
farming is the main industry. A complete enumeration
survey was conducted in the ﬁrst wave of the KSHAP on
94.7% (n=814) of the target population (n=860) between
December 2011 and July 2012. The KSHAP-Health
Examination (KSHAP-HE) cohort consists of 698 people
who completed additional health examinations at a
public health centre or at their home. The sampling and
data collection procedures have been described in detail
elsewhere.15 In this study, 129 participants were excluded
for missing key variables (n=85); history of stroke, angina
pectoris or myocardial infarction (n=32); or CRP levels
above 20 mg/L (n=12). Ultimately, a total of 569 partici-
pants (224 men and 345 women) were included for cross-
sectional analyses. All participants provided written
informed consent forms.
Questionnaire data
All participants were interviewed by trained personnel
using standardised questionnaires according to the pre-
developed protocol. In addition, the designated ﬁeld dir-
ector double-checked whether answers were missing or
inappropriate and continuously monitored the entire
interview process. Sociodemographic variables included
age, education (uneducated, elementary school, middle
school or high school+) and marital status (with or
without spouse). Health behaviours included smoking
status, alcohol intake and sleep duration. Smoking status
was classiﬁed into two groups: current smokers or
current non-smokers (past smokers or never smokers).
Alcohol intake was categorised as follows: regular
alcohol drinkers or others (participants who drink
under once a week or never alcohol drinkers). Sleep
duration was collected in hours per day (h/day) as the
average during the past year. The presence of comorbid-
ities were assessed by self-report and included diseases as
follows: hypertension, diabetes mellitus, metabolic syn-
drome, dyslipidaemia, osteoporosis, cancer, stroke, myo-
cardial infarction, angina pectoris, arthritis, pulmonary
tuberculosis, asthma, cataract, glaucoma, hepatitis B,
depression, urinary incontinence and benign prostatic
hyperplasia. Depressive symptoms were measured using
the Korean version of the Center for Epidemiologic
Studies Depression (CES-D) scale, a 20-item, self-report
scale designed to measure depressive symptoms experi-
enced during the previous week.16 The scale, ranging
from 0 to 60, has been shown to be a valid and reliable
instrument in older populations.17 The underlying
structure of the CES-D consists of four dimensions of
depression: seven items measure depressed affect, four
items measure positive affect, two items measure inter-
personal difﬁculties and seven items measure somatic
symptoms.
Physical examination
All participants wore lightweight hospital gowns for con-
venient and reliable examinations. Standing height was
measured to the nearest 0.1 cm using a stadiometer and
body weight was measured to the nearest 0.1 kg on a
digital scale. Body mass index (BMI) was calculated as
body weight in kilograms divided by standing height in
metres squared (kg/m2). Participants were seated for at
least 5 min before blood pressure measurement, and
two measurements were taken within at least 5 min using
an automatic sphygmomanometer (Dinamap 1846 SX/P;
GE Healthcare, Waukesha, Wisconsin, USA). If the two
measurements differed by ≥10 mmHg for systolic blood
pressure (SBP) or diastolic blood pressure (DBP), a third
measurement was taken after 5 min, and the last two mea-
surements were averaged for analysis.
Laboratory test
Blood samples were collected from the antecubital vein
of participants after at least 8 h of fasting. Collected
blood samples were analysed at a central research labora-
tory for serum CRP, total cholesterol, high-density lipo-
protein cholesterol, triglycerides, glucose and so on. CRP
levels, a marker of acute systemic inﬂammation, were
determined in accordance with turbidimetric immuno-
assay with an ADVIA1800 Auto Analyzer (Siemens
medical Sol., USA). The interassay coefﬁcient of variation
for CRP was from 0.38% to 1.53% and results were
expressed as mg/L.
Statistical analysis
We evaluated differences in clinical and demographic
characteristics between men and women. CRP level,
CES-D scale and several confounding factors were signiﬁ-
cantly different between men and women. Therefore,
we performed all analyses separately by sex. Continuous
variables were described as mean and SD (for normally
distributed variables) or as median and IQR (for skewed
variables), and tested by independent t test and Wilcoxon
rank sum test, respectively. Categorical variables were
described as numbers with percentage and tested by a χ2
test. General characteristics and concentrations of
selected biomarkers were also analysed according to
three categories of depression score. One-way analysis of
variance was used for continuous variables and χ2 test was
used for categorical variables. For this analysis, the trend
test was used. For the continuous variables, p values were
calculated by using a contrast to test for a linear trend.
For the categorical variables, the Cochran-Armitage test
and the Mantel-Haenszel test were used. The relation-
ships between depression score and other variables were
evaluated using Pearson’s correlation coefﬁcients.
Multiple linear regression analyses were used to assess the
independent association between serum CRP and depres-
sion score in the unadjusted model and two adjusted
models: (1) adjusting for age, BMI, SBP, number of
comorbidities, smoking status and alcohol intake; (2)
additional adjustment for marital status, sleep duration
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and education. All statistical analyses were performed
using SAS V.9.2 (SAS Institute, Cary, North Carolina,
USA), and statistical signiﬁcance was deﬁned as two-sided
p value less than 0.05.
RESULTS
Clinical and demographic characteristics of the study
participants are presented in table 1. This study con-
sisted of 224 men with a mean age of 72.8 years and 345
women with a mean age of 71.6 years. The median CRP
level was signiﬁcantly higher in men than in women (1.0
vs 0.8 mg/L, p<0.001), but the median CES-D scale was
signiﬁcantly lower in men than in women (6 vs 8,
p=0.007).
Table 2 shows the characteristics of the study partici-
pants according to the CES-D tertile. Both men and
women with higher CES-D categories tended to be older
and have more number of comorbidities. In men,
higher CES-D categories were associated with higher
CRP level (p=0.038), lower education level and no
spouse (divorced, widowed and unmarried). However, in
women, the CED-D tertile was not associated with the
CRP level (p=0.465).
Table 3 shows correlations between depression score
and other variables. In the unadjusted model, depres-
sion score was positively associated with age, SBP,
number of comorbidities and CRP in men. In women,
depression score was positively associated with age and
number of comorbidities; however, the association with
CRP was not signiﬁcant. Figure 1 presents the nature of
relationship between depression score and log-
transformed CRP, separately for men and women.
Table 4 presents the association between depression
score and serum CRP in serial multiple linear regression
models. In men, higher CRP levels were signiﬁcantly
associated with increased depression score (β=0.365,
p=0.017) when adjusted for age, BMI, SBP, number of
comorbidities, smoking status and alcohol intake
(model 1). The association still remained signiﬁcant
(β=0.336, p=0.025) when additionally adjusted for
marital status, sleep duration and education (model 2).
However, in women, the associations between CRP level
and depression score were not signiﬁcant in the
unadjusted model and two adjusted models.
DISCUSSION
This study investigated the independent association
between serum CRP levels and depressive symptoms in
an elderly Korean population. Our ﬁndings suggest that
elevated levels of CRP are independently associated with
depressive symptoms in elderly Korean men.
Our results are consistent with previous ﬁndings
linking elevated CRP levels to depression.5 9 11 18 In the
Table 1 Characteristics of study participants
Variables Total (n=569) Men (n=224) Women (n=345) p Value
Age, year 72.1±7.6 72.8±6.7 71.6±8.2 0.070
Body mass index, kg/m2 24.0±3.4 23.7±3.5 24.2±3.4 0.073
Systolic BP, mm Hg 134.2±20.0 133.0±19.7 135.1±20.1 0.225
Diastolic BP, mm Hg 72.1±9.9 73.2±10.2 71.5±9.7 0.047
Total cholesterol, mg/dL 184.0±35.1 173.1±33.5 191.1±34.4 <0.001
HDL cholesterol, mg/dL 51.4±12.8 51.1±13.6 51.6±12.2 0.668
LDL cholesterol, mg/dL 102.1±30.8 92.6±28.6 108.1±30.6 <0.001
Triglycerides, mg/dL 138 [102–189] 128 [93–176] 142 [105–193] 0.011*
CRP, mg/L 0.8 [0.5–1.6] 1.0 [0.6–2.1] 0.8 [0.4–1.4] <0.001*
Hypertension 369 (64.9) 139 (62.1) 230 (66.7) 0.300†
Diabetes mellitus 122 (21.4) 53 (23.7) 69 (20.0) 0.350†
Dyslipidaemia 243 (42.7) 86 (38.4) 157 (45.5) 0.112†
Number of comorbidities 1.9±1.5 1.4±1.3 2.2±1.5 <0.001
Current smoker 70 (12.3) 64 (28.6) 6 (1.7) <0.001†
Regular alcohol drinker 117 (20.6) 96 (42.9) 21 (6.1) <0.001†
Sleep duration, h 8.5±1.4 8.4±1.4 8.5±1.4 0.201
Education
Uneducated 167 (29.6) 25 (11.2) 142 (41.6) <0.001†
Elementary school 240 (42.6) 97 (43.5) 143 (41.9)
Middle school 83 (14.7) 52 (23.3) 31 (9.1)
High school or higher 74 (13.1) 49 (22.0) 25 (7.3)
No spouse (divorced, widowed and unmarried) 138 (24.3) 16 (7.1) 122 (35.4) <0.001†
CES-D 7 [4–14] 6 [3–13] 8 [4–15] 0.007*
CES-D ≥16 124 (21.8) 41 (18.3) 83 (24.1) 0.128†
Data are expressed as means±SD, medians [IQR] or numbers (%).
LDL cholesterol levels were calculated for 558 participants (217 men and 341 women).
Education levels were measured for 564 participants (223 men and 341 women).
p Value was derived from an independent t test, Wilcoxon rank sum test* or χ2 test†.
Abbreviations: BP, blood pressure; CES-D, Center for Epidemiologic Studies Depression; CRP, C reactive protein; HDL, high-density
lipoprotein; LDL, low-density lipoprotein.
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Table 2 Characteristics of study participants by CES-D tertile
Variables Men (n=224) Women (n=345)
0–3 (n=65) 4–10 (n=85) 11+ (n=74) p Trend 0–5 (n=123) 6–12 (n=107) 13+ (n=115) p Trend
Age, year 69.7±5.8 73.0±6.2 75.2±7.1 <0.001 70.8±8.3 71.1±7.4 73.1±8.5 0.031
Body mass index, kg/m2 24.0±3.9 24.0±3.1 23.1±3.4 0.124 24.2±3.3 24.4±3.3 24.0±3.5 0.685
Systolic BP, mm Hg 133.1±20.1 130.1±18.7 136.2±20.4 0.358 137.9±22.1 132.6±17.6 134.4±19.9 0.178
Diastolic BP, mm Hg 75.2±11.1 72.0±9.4 72.7±10.2 0.156 72.6±9.9 71.8±9.1 70.0±9.9 0.038
Total cholesterol, mg/dL 179.7±38.3 176.1±30.7 163.9±30.1 0.005 191.1±35.6 189.7±33.3 192.3±34.3 0.798
HDL cholesterol, mg/dL 50.4±13.0 51.2±11.7 51.6±16.1 0.603 51.3±12.0 50.8±11.7 52.5±12.9 0.467
LDL cholesterol, mg/dL 95.7±29.0 95.9±29.4 86.3±26.5 0.059 107.2±30.9 107.4±30.4 109.7±30.8 0.539
Triglycerides, mg/dL 131 [97–187] 135 [94–193] 120 [89–150] 0.009 146 [106–201] 141 [107–188] 142 [99–193] 0.418
CRP, mg/L 0.8 [0.5–1.5] 1.3 [0.6–2.2] 1.1 [0.5–3.0] 0.038 0.8 [0.4–1.3] 0.7 [0.5–1.3] 0.8 [0.4–1.6] 0.465
Hypertension 34 (52.3) 52 (61.2) 53 (71.6) 0.019* 85 (69.1) 71 (66.4) 74 (64.4) 0.436*
Diabetes mellitus 14 (21.5) 17 (20.0) 22 (29.7) 0.241* 19 (15.5) 22 (20.6) 28 (24.4) 0.086*
Dyslipidaemia 26 (40.0) 40 (47.1) 20 (27.0) 0.099* 57 (46.3) 50 (46.7) 50 (43.5) 0.662*
Number of comorbidities 1.0±1.3 1.5±1.2 1.8±1.4 <0.001 1.8±1.4 2.2±1.5 2.5±1.6 0.001
Current smoker 18 (27.7) 22 (25.9) 24 (32.4) 0.146† 3 (2.4) 1 (0.9) 2 (1.7) 0.669†
Regular alcohol drinker 28 (43.1) 36 (42.4) 32 (43.2) 0.572† 6 (4.9) 9 (8.4) 6 (5.2) 0.892†
Sleep duration, h 8.2±1.2 8.5±1.5 8.5±1.5 0.218 8.5±1.4 8.4±1.5 8.7±1.4 0.391
Education
Uneducated 4 (6.2) 8 (9.4) 13 (17.8) <0.001† 45 (36.6) 48 (45.3) 49 (43.8) 0.054†
Elementary school 24 (36.9) 39 (45.9) 34 (46.6) 54 (43.9) 40 (37.7) 49 (43.8)
Middle school 17 (26.2) 16 (18.8) 19 (26.0) 9 (7.3) 13 (12.3) 9 (8.0)
High school or higher 20 (30.8) 22 (25.9) 7 (9.6) 15 (12.2) 5 (4.7) 5 (4.5)
No spouse (divorced, widowed and unmarried) 0 (0.0) 4 (4.7) 12 (16.2) <0.001* 42 (34.2) 34 (31.8) 46 (40.0) 0.354*
Data are expressed as means±SD, medians [IQR] or numbers (%).
The p for trend was derived from a general linear model using contrast coefficients, the Cochran-Armitage trend test* or the Mantel-Haenszel test†.
BP, blood pressure; CES-D, Center for Epidemiologic Studies Depression; CRP, C reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
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Health, Aging and Body Composition Study, high levels
of inﬂammatory markers including CRP, interleukin 6
(IL-6) and tumour necrosis factor α (TNF-α) were asso-
ciated with depressive symptoms which are measured
with the CES-D scale.5 Moreover, in older people with
metabolic syndrome, CRP levels were independently
associated with depressive symptoms after adjusting
for sex, age, education, smoking status, cognitive func-
tion, metabolic syndrome, hypertension, diabetes and
medication.11 Lastly, a systemic review and meta-analysis
of longitudinal studies which are conducted across all
age groups found that raised inﬂammatory markers
including CRP and IL-6 have a small but signiﬁcant asso-
ciation with the subsequent development of depressive
symptoms after adjustment for age and a wide range of
factors associated with risk for depression.9 Contrary to
these studies, however, several studies did not ﬁnd inde-
pendent associations between CRP levels and depressive
symptoms.10 19 20 In two elderly population studies, ele-
vated CRP levels were associated with higher CES-D
score, but not after adjustment for confounding
factors.10 19 In the prospective Sydney Memory and
Aging Study, CRP levels were not associated with depres-
sive symptoms, whereas IL-8 was associated with depres-
sive symptoms at baseline and at 2-year follow-up.20
The relationship between inﬂammation and depression
is potentially bidirectional, and the underlying mechan-
isms are still poorly understood. First, inﬂammation may
lead to depression. Increased inﬂammatory markers con-
tribute to decreases in serotonin, an important neurotrans-
mitter in the pathogenesis of depression.21–23 Second,
depression may lead to inﬂammation. Psychological stress
activates the sympathetic nervous system and releases stress
hormones. These hormones in turn initiate acute-phase
responses triggering inﬂammation.24–26
In our study, CRP levels were signiﬁcantly associated
with depressive symptoms in men but not in women. This
ﬁnding is consistent with a few previous reports.27–29 In an
obese clinical population, depressive symptoms were sig-
niﬁcantly associated with CRP in men only, even after
adjusting for age, obesity, metabolic variables and medica-
tions known to affect inﬂammation. This ﬁnding suggests
that there are biological differences between men and
women that may modify the relationship between CRP
levels and depression.28 In the third National Health and
Nutrition Examination Survey (NHANES III), depression
and elevated CRP levels were more common in women
than in men, but the association between CRP levels and
depression was signiﬁcant only in men.29 They hypothe-
sised that CRP levels might vary by the hormonal environ-
ment. In the Health 2000 Survey, depressive symptoms
were independently associated with systemic inﬂammation
processes in men, but not in women.27 They suggest that
Table 3 Pearson’s correlation coefficients between depression score and other variables
Variables
Men (n=224) Women (n=345)
Correlation coefficient p Value Correlation coefficient p Value
Age 0.333 <0.001 0.177 <0.001
Body mass index −0.099 0.142 −0.064 0.236
Systolic BP 0.144 0.031 −0.015 0.785
Diastolic BP 0.020 0.771 −0.061 0.261
Sleep duration 0.045 0.506 0.050 0.359
Number of comorbidities 0.268 <0.001 0.232 <0.001
CRP* 0.140 0.036 0.055 0.312
*Analysed with log-transformed values.
BP, blood pressure; CRP, C reactive protein.
Figure 1 Association score between depression score and
C reactive protein (CRP).
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depression may have a different psychological and physio-
logical meaning and background for men and women.
Our study participants were the elderly population aged
60 years or older. Therefore, our ﬁndings that there was a
signiﬁcant association between CRP levels and depressive
symptoms in men only are probably because the main
factors inﬂuencing on depression differ rather than hor-
monal environments or biological features differ between
men and women.
Our study has a few distinctions compared with previ-
ous studies. The study participants were recruited from a
community of single ethnic background. Furthermore,
we carefully controlled various covariates known to be
related to inﬂammation and depression in the analyses.
These enabled us to evaluate the independent associ-
ation between the inﬂammatory marker and depressive
symptoms. To the best of our knowledge, this study is
the ﬁrst to demonstrate that serum CRP levels are asso-
ciated with depressive symptoms in elderly Koreans. We
also observed the gender difference in the association
between CRP levels and depressive symptoms among
general elderly Koreans.
The study has some limitations. First, since this is a cross-
sectional study in which all information was collected at
the same point in time, no deﬁnitive conclusion about the
direction of the associations between CRP levels and
depressive symptoms could be reached. Second, we relied
on a single blood sample per individual. However, circulat-
ing CRP levels obtained from one time point have been
shown to represent systemic low-grade inﬂammation.30
Third, inﬂammatory markers other than CRP were not
measured in this study. Further studies including other
inﬂammatory markers needed to conﬁrm our results.
Fourth, we investigated depressive symptoms using the
CES-D scale, which has been widely used to assess depres-
sion and its risk factors in population-based studies.17 16
However, the validity of CES-D is inferior to the psychiatric
diagnostic interview, the gold standard.31 Fifth, we did not
use a validated measure of comorbidity such as the
Charlson Comorbidity index because comorbidity compo-
nents of the Charlson Comorbidity index were not
matched with the comorbidities asked for in this study.
However, many epidemiological studies have used a
number of selected chronic disorders to measure general
health conditions of elderly people.1 20 32 Sixth, we could
not control the effects of medications such as hormone-
replacement therapy, anti-inﬂammatory medications and
antidepressants. Alternatively, we additionally analysed
after excluding 11 people with a history of depression.
A similar result was observed (online supplementary
table S1). Lastly, the study participants were recruited from
a single rural community and the sample size was relatively
small. Consequently, our ﬁndings may not be generalisable
to the other older population.
In conclusion, our ﬁndings suggest that high serum
CRP levels are independently associated with depressive
symptoms in community-dwelling elderly Korean men,
even after adjusting for several physical and psychological
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factors. Chronic inﬂammation may be another possible
risk factor for depressive symptoms in elderly Koreans.
Further studies are needed to establish a causal relation-
ship between inﬂammation and depression and to investi-
gate the underlying mechanisms by sex and speciﬁc
population.
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